SUNROCK
SunRock is a biotech company that engages in the development of antibodies against highly invasive tumors.
SUNROCK
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Santiago De Compostela, Galicia, Spain
Country:
Spain
Website Url:
http://www.sunrockbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
34 881 975 523
Email Addresses:
[email protected]
Technology used in webpage:
ReCAPTCHA WPForms Ahosting DINA Hosting
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Anaconda Pharma
Anaconda Pharma is a biopharmaceutical company focusing on the development of treatments for infections by human papillomavirus (HPV).
Atriva Therapeutics
Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.
Juvenescence
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
LiteVax
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.
LPS-BioSciences
LPS-BioSciences is a biotechnical company that focuses on the research and development of vaccines, diagnostics and endotoxins.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Quercis Pharma
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.sunrockbiopharma.com
- Host name: hw104.dinaserver.com
- IP address: 82.98.168.70
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "SunRock"
SunRock - Crunchbase Company Profile & Funding
Organization. SunRock . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 34 881 975 523; Lists Featuring …See details»
SunRock Biopharma | SunRock
Model. SunRock Biopharma follows a disruptive methodology for drug development based on an open innovation model. In collaboration with the main research centers and key opinion leaders of the biotechnology innovation …See details»
SunRock Biopharma
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious …See details»
SunRock Company Profile 2024: Valuation, Funding
SunRock General Information Description. Developer of therapeutic antibodies designed to help patients fight against cancer. The company's antibodies help to tackle crucial regulatory hubs in many kinds of cancer, triple-negative breast …See details»
SunRock Biopharma - Overview, News & Similar companies
Sep 21, 2023 View SunRock Biopharma (www.sunrockbiopharma.com) location in Galicia, Spain , revenue, industry and description. Find related and similar companies as well as …See details»
Sunrock Biopharma SL - Drug pipelines, Patents, Clinical trials
Www.sunrockbiopharma.com. Last update 31 Dec 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
SunRock Biopharma, S.L | LinkedIn
SunRock is a biopharmaceutical company, developing sophisticated therapeutic antibodies under innovative formats antibodies to treat incurable cancer. SunRock, working under an open …See details»
SUNROCK BIOPHARMA SOCIEDAD LIMITADA. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SUNROCK BIOPHARMA SOCIEDAD LIMITADA. of SANTIAGO DE COMPOSTELA, La Coruña. Get the …See details»
SunRock Biopharma, S.L: Contact Details and Business Profile
What is the annual revenue of SunRock Biopharma, S.L? The SunRock Biopharma, S.L annual revenue was $6 million in 2024.See details»
SunRock Biopharma - Company Profile - Tracxn
Nov 27, 2024 SunRock Biopharma develops therapeutic antibodies against cancer. The company has 2 candidates: the first is an antibody targeting CCR9 for T-cell Acute …See details»
SunRock Biopharma - Products, Competitors, Financials, …
Sunrockbiopharma.com. Overview & Products; Founded Year 2014. Mosaic Score. The Mosaic Score is an algorithm that measures the overall financial health and market potential of private …See details»
Sunrock Biopharma | VentureRadar
Website: http://www.sunrockbiopharma.com/ SunRock Biopharma develops therapeutic antibodies against cancer. Currently SunRock’s efforts are concentrated into two ...See details»
SunRock Biopharma - Cluster Transfronterizo Biotecnológico
Www.sunrockbiopharma.com; SunRock Biopharma Description. SunRock Biopharma is dedicated to developing therapeutic antibodies to fight cancer. Currently SunRock Biopharma’s efforts …See details»
Cluster Transfronterizo Biotecnológico
[email protected]; Edificio CIMUS. Avenida Barcelona, s/n, C.P. 15782 Santiago de Compostela. A Coruña; www.sunrockbiopharma.com; SunRock Biopharma Descripción. …See details»
Debiopharm Extends SunRock Biopharma Partnership for …
Jan 8, 2024 Lausanne, Switzerland, and Santiago De Compostela, Spain – January 8th, 2024 – Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical …See details»
SunRock Biopharma - Socios Bioga
SunRock Biopharma es una empresa biofarmacéutica constituida con el objetivo de desarrollar y comercializar anticuerpos terapéuticos dirigidos contra distintos tipos de patologías tumorales …See details»
Currently at SRB - SunRock Biopharma
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious …See details»
Pipeline - SunRock Biopharma
We use (our own and third-party) cookies for personalisation and advertising purposes to create profiles based on your web browsing history, for example, to show you personalised content.See details»
HER3 - SunRock Biopharma
SunRock, in collaboration with the University of Stuttgart (Germany), has developed SRB17, a best-in-class fully human IgG anti-HER3 with improved affinity and a dual mechanism of …See details»